Literature DB >> 16696024

Identification of a thrombin receptor with factor Xa receptor and tissue factor in human pancreatic carcinoma cells.

A K Kakkar1, N R Lemoine, S R Stone, D Altieri, R C Williamson.   

Abstract

Venous thromboembolism is a common feature of pancreatic cancer. The underlying mechanism is unclear, but is likely to involve thrombin generation on the cell surface. Human pancreatic carcinoma cell lines (n=8) have been studied immmunohistochemically for the expression of tissue factor, factor Xa receptor, and thrombin receptor. Each antigen had a distinct pattern of immunoreactivity in cell membrane and cytoplasm. Tissue factor was predominantly localised to the membrane, whereas thrombin and factor Xa receptor were largely cytoplasmic in distribution. The results support the hypothesis of a coagulation cascade that starts with tissue factor, leads to thrombin generation, and might confer a biological advantage on tumour cells.

Entities:  

Year:  1995        PMID: 16696024      PMCID: PMC407987          DOI: 10.1136/mp.48.5.m288

Source DB:  PubMed          Journal:  Clin Mol Pathol        ISSN: 1355-2910


  14 in total

1.  Coagulation factors X, Xa, and protein S as potent mitogens of cultured aortic smooth muscle cells.

Authors:  G P Gasic; C P Arenas; T B Gasic; G J Gasic
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

2.  Role of thrombin in the proliferative response of T-47D mammary tumor cells. Mitogenic action and pleiotropic modifications induced together with epidermal growth factor and insulin.

Authors:  E E Medrano; E G Cafferata; F Larcher
Journal:  Exp Cell Res       Date:  1987-10       Impact factor: 3.905

3.  Molecular cloning of effector cell protease receptor-1, a novel cell surface receptor for the protease factor Xa.

Authors:  D C Altieri
Journal:  J Biol Chem       Date:  1994-02-04       Impact factor: 5.157

4.  Tissue factor expression correlates with histological grade in human pancreatic cancer.

Authors:  A K Kakkar; N R Lemoine; M F Scully; S Tebbutt; R C Williamson
Journal:  Br J Surg       Date:  1995-08       Impact factor: 6.939

5.  Thrombin stimulates tumor-platelet adhesion in vitro and metastasis in vivo.

Authors:  M L Nierodzik; A Plotkin; F Kajumo; S Karpatkin
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

6.  Enhancement of the expression of urokinase-type plasminogen activator from PC-3 human prostate cancer cells by thrombin.

Authors:  E Yoshida; E N Verrusio; H Mihara; D Oh; H C Kwaan
Journal:  Cancer Res       Date:  1994-06-15       Impact factor: 12.701

Review 7.  Cancer cell procoagulants and their implications.

Authors:  S G Gordon
Journal:  Hematol Oncol Clin North Am       Date:  1992-12       Impact factor: 3.722

Review 8.  Fibrin as a component of the tumor stroma: origins and biological significance.

Authors:  H F Dvorak; D R Senger; A M Dvorak
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

9.  Inhibition of murine melanoma experimental metastasis by recombinant desulfatohirudin, a highly specific thrombin inhibitor.

Authors:  N Esumi; D Fan; I J Fidler
Journal:  Cancer Res       Date:  1991-09-01       Impact factor: 12.701

Review 10.  Cancer and thrombosis.

Authors:  M B Donati
Journal:  Haemostasis       Date:  1994 Mar-Apr
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.